These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9026537)

  • 1. ApoA-II kinetics in humans using endogenous labeling with stable isotopes: slower turnover of apoA-II compared with the exogenous radiotracer method.
    Ikewaki K; Zech LA; Brewer HB; Rader DJ
    J Lipid Res; 1996 Feb; 37(2):399-407. PubMed ID: 9026537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of apoA-I kinetics in humans using simultaneous endogenous stable isotope and exogenous radiotracer methods.
    Ikewaki K; Rader DJ; Schaefer JR; Fairwell T; Zech LA; Brewer HB
    J Lipid Res; 1993 Dec; 34(12):2207-15. PubMed ID: 8301239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed catabolism of high density lipoprotein apolipoproteins A-I and A-II in human cholesteryl ester transfer protein deficiency.
    Ikewaki K; Rader DJ; Sakamoto T; Nishiwaki M; Wakimoto N; Schaefer JR; Ishikawa T; Fairwell T; Zech LA; Nakamura H
    J Clin Invest; 1993 Oct; 92(4):1650-8. PubMed ID: 8408618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
    Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
    J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II.
    Rader DJ; Castro G; Zech LA; Fruchart JC; Brewer HB
    J Lipid Res; 1991 Nov; 32(11):1849-59. PubMed ID: 1770304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of high density lipoprotein subfractions and constituents in Tangier disease following the infusion of high density lipoproteins.
    Schaefer EJ; Anderson DW; Zech LA; Lindgren FT; Bronzert TB; Rubalcaba EA; Brewer HB
    J Lipid Res; 1981 Feb; 22(2):217-28. PubMed ID: 6787156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human apolipoprotein A-I and A-II metabolism.
    Schaefer EJ; Zech LA; Jenkins LL; Bronzert TJ; Rubalcaba EA; Lindgren FT; Aamodt RL; Brewer HB
    J Lipid Res; 1982 Aug; 23(6):850-62. PubMed ID: 6813411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein B-100 and apoA-II kinetics as determinants of cellular cholesterol efflux.
    Chan DC; Hoang A; Barrett PH; Wong AT; Nestel PJ; Sviridov D; Watts GF
    J Clin Endocrinol Metab; 2012 Sep; 97(9):E1658-66. PubMed ID: 22745238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I.
    Batal R; Tremblay M; Krimbou L; Mamer O; Davignon J; Genest J; Cohn JS
    Arterioscler Thromb Vasc Biol; 1998 Apr; 18(4):655-64. PubMed ID: 9555873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evidence for increased apolipoprotein A-I catabolism in subjects with impaired glucose tolerance.
    Pietzsch J; Julius U; Nitzsche S; Hanefeld M
    Diabetes; 1998 Dec; 47(12):1928-34. PubMed ID: 9836526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subjects with ApoA-I(Lys107-->0) exhibit enhanced fractional catabolic rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI with AII).
    Tilly-Kiesi M; Lichtenstein AH; Ordovas JM; Dolnikowski G; Malmström R; Taskinen MR; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 1997 May; 17(5):873-80. PubMed ID: 9157950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal HDL apolipoprotein A-I and A-II kinetics in hemodialysis patients: a stable isotope study.
    Okubo K; Ikewaki K; Sakai S; Tada N; Kawaguchi Y; Mochizuki S
    J Am Soc Nephrol; 2004 Apr; 15(4):1008-15. PubMed ID: 15034103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.
    Brinton EA; Eisenberg S; Breslow JL
    Arterioscler Thromb; 1994 May; 14(5):707-20. PubMed ID: 8172849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins.
    Vélez-Carrasco W; Lichtenstein AH; Barrett PH; Sun Z; Dolnikowski GG; Welty FK; Schaefer EJ
    J Lipid Res; 1999 Sep; 40(9):1695-700. PubMed ID: 10484617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoprotein apolipoprotein A-I kinetics: comparison of radioactive and stable isotope studies.
    Ooi EM; Watts GF; Farvid MS; Chan DC; Allen MC; Zilko SR; Barrett PH
    Eur J Clin Invest; 2006 Sep; 36(9):626-32. PubMed ID: 16919045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contents of apolipoprotein A-I, A-II and B of the human serum fractions for high-density and low-density lipoproteins prepared by common precipitation methods.
    Väisänen S; Gävert J; Julkunen A; Voutilainen E; Penttilä I
    Scand J Clin Lab Invest; 1992 Dec; 52(8):853-62. PubMed ID: 1488623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo metabolism of apolipoprotein A-IV in severe hypertriglyceridemia: a combined radiotracer and stable isotope kinetic study.
    Vergès B; Rader D; Schaefer J; Zech L; Kindt M; Fairwell T; Gambert P; Brewer HB
    J Lipid Res; 1994 Dec; 35(12):2280-91. PubMed ID: 7897325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic evidence for both a fast and a slow secretory pathway for apolipoprotein A-I in humans.
    Fisher WR; Venkatakrishnan V; Zech LA; Hall CM; Kilgore LL; Stacpoole PW; Diffenderfer MR; Friday KE; Sumner AE; Marsh JB
    J Lipid Res; 1995 Jul; 36(7):1618-28. PubMed ID: 7595084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein A-I Milano: sex-related differences in the concentration and composition of apoA-I- and apoB-containing lipoprotein particles.
    Bekaert ED; Alaupovic P; Knight-Gibson CS; Franceschini G; Sirtori CR
    J Lipid Res; 1993 Jan; 34(1):111-23. PubMed ID: 8445335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.